This predominance of small, dense LDL particles has been termed the atherogenic lipoprotein profile (ALP) and is linked to several metabolic issues that help explain its atherogenicity.
In conclusion, detection of the small LDL trait in patients without clinical CAD allows greater insight into their individual cardiovascular risk. The presence of predominantly small LDL in an ...